A closer look at the technologies used by Glenmark Pharmaceuticals South Africa
Glenmark Pharmaceuticals South Africa
Manufacturing · South Africa · <25 Employees
View Company Info for Free
About
Headquarters
South AfricaPhone Number
+27 115643900Website
www.glenmarkpharma.co.zaRevenue
<$5 MillionIndustry
Recent News & Media
No recent news or media
Who is Glenmark Pharmaceuticals South Africa
Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecu les in various stages of clinical development & pre-clinical development. The company has a significant presence in branded generics markets across emerging economies including India. It's subsidiary, Glenmark Generics Limited has a fast growing and robust US generics business. The subsidiary also markets APIs to regulated and semi-regulated countries. Glenmark employs over 10,400 people in over 80 countries. It has 14 manufacturing facilities in four countries and has 6 R&D centres. Since getting listed on the stock exchange in 2000, when Glenmark registered revenue of USD 32 Mn, the company is currently ranked among the World's top 100 Pharma & Biotech companies*. Recently, Glenmark has been chosen as the 'Best Company Across Emerging Markets' 2011, and recognized for the 'Best Overall Pipeline' 2011 by SCRIP, the largest selling and most respected pharmaceutical magazine in the world. SCRIP had also recognized Glenmark as 'Best Pharma Company in the World - SME' and 'Best Company in an Emerging Market' in 2008. OTHER AWARDS AND RECOGNITIONS RECEIVED BY THE COMPANY INCLUDE THE "BEST UNDER A BILLION DOLLAR COMPANIES IN ASIA" FOR 2008 BY FORBES, A LEADING INTERNATIONAL PUBLICATION, "INDIAN INNOVATOR PHARMACEUTICAL COMPANY OF THE YEAR - 2010" BY FROST & SULLIVAN, AND GOLD PATENT AWARD 2011 IN THE CATEGORIES OF API FORMULATIONS & EXPORT OF BULK DRUGS (NON BIOLOGICALS) BY PHARMEXCIL. About UsRead more
Popular SearchesGlenmark Pharmaceuticals LtdSIC Code 28,283NAICS Code 32,325Show moreIs Glenmark Pharmaceuticals South Africa your ideal customer?
Let us give you the heads up on whether it's a good time to reach out
Check if Glenmark Pharmaceuticals South Africa has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Glenmark Pharmaceuticals South Africa has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Glenmark Pharmaceuticals South Africa
Earning: See what the market has to say on Glenmark Pharmaceuticals South Africa recently announced quarterly report
Click to see if Glenmark Pharmaceuticals South Africa had a recent Job posting/layoffs
Check out if Glenmark Pharmaceuticals South Africa is spiking on competitors!
Product Launch: Get notified when Glenmark Pharmaceuticals South Africa launches new products
Website visits: Recent activity has been detected on your website
Glenmark Pharmaceuticals South Africa, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Glenmark Pharmaceuticals South Africa
Find 3 more new buyers
Glenmark Pharmaceuticals South Africa Employee Growth Rate
Percentage of growth
1st year Mask
2nd year Mask
Glenmark Pharmaceuticals South Africa Tech Stack
Most Recent Scoops
Frequently Asked Questions Regarding Glenmark Pharmaceuticals South Africa
Glenmark is a leading player in the discovery of new molecules, both NCEs (new chemical entity) and NBEs (new biological entity), with seven molecules in various stages of clinical development & pre-clinical development. The company has a significant presence in branded generics markets across emerging economies including India. It's subsidiary, Gl... Read More